Commercial And Military Flight Simulation - Global Strategic Business Report
- Language: English
- 774 Pages
- Published: October 2012
- Region: World
Nycomed International Management GmbH Market Share Analysis
Summary
Our new report, Nycomed’s Market Share Analysis” provides in-depth information on Nycomed’s market position in the different medical equipment markets it operates in. The report provides Nycomed’s market share information in one market category – Wound Closure Devices..The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts
Scope
- Global company shares (in Revenues) information for the key markets Nycomed International Management GmbH operates in – Wound Care Management.
- Nycomed’s company shares (in Revenues) information for all the key countries the company has presence
READ MORE >
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Wound Care Management
3.1.1 Advanced Wound Management
3.1.2 Automated Suturing Devices
3.1.3 Compression Therapy
3.1.4 Negative Pressure Wound Therapy (NPWT)
3.1.5 Ostomy Drainage Bags
3.1.6 Pressure Relief Devices
3.1.7 Traditional Wound Management
3.1.8 Wound Closure Devices
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 SWOT Snapshot
4.4 Business Overview
4.5 Major Products and Services
4.5.1 Overview
5 History
6 SWOT Analysis
6.1 Overview
6.2 Nycomed International Management GmbH Strengths
6.2.1 Strong In-house Research Capabilities
6.2.2 Blockbuster Product: Pantoprazole
6.2.3 Widespread Geographic Presence
6.3 Nycomed International Management GmbH Weaknesses
6.3.1 Patent Expiration: Pantoprazole
6.4 Nycomed International Management GmbH Opportunities
6.4.1 Pipeline Products
6.4.2 Agreements and Collaborations
6.4.3 New Product Approvals
6.4.4 Changing Population Trends
6.5 Nycomed International Management GmbH Threats
6.5.1 Increased Generic Competition
6.5.2 Government Regulations
6.5.3 Uncertain R&D Outcomes
7 Competitors
8 Competitive Landscape
8.1 Wound Care Management, Global, Market Share (%), 2009
9 Nycomed International Management GmbH Medical Equipment Market Share Analysis
9.1 Nycomed International Management GmbH, Wound Care Management, Global, Market Share (2009)
9.2 Nycomed International Management GmbH, Asia-Pacific, Market Share (2009)
9.3 Nycomed International Management GmbH, Europe, Market Share (2009)
9.4 Nycomed International Management GmbH, Middle East and Africa, Market Share (2009)
9.5 Nycomed International Management GmbH, North America, Market Share (2009)
9.6 Nycomed International Management GmbH, South and Central America, Market Share (2009)
10 Nycomed International Management GmbH Medical Equipment Market Share Analysis by Category
10.1 Nycomed International Management GmbH, Wound Care Management, Global, Category Revenue Share (2009)
10.2 Nycomed International Management GmbH, Asia-Pacific, Category Revenue Share (2009)
10.2.1 Nycomed International Management GmbH, Australia, Category Revenue Share (2009)
10.2.2 Nycomed International Management GmbH, China, Category Revenue Share (2009)
10.2.3 Nycomed International Management GmbH, Japan, Category Revenue Share (2009)
10.2.4 Nycomed International Management GmbH, Other Asia-Pacific, Category Revenue Share (2009)
10.3 Nycomed International Management GmbH, Europe, Category Revenue Share (2009)
10.3.1 Nycomed International Management GmbH, France, Category Revenue Share (2009)
10.3.2 Nycomed International Management GmbH, Germany, Category Revenue Share (2009)
10.3.3 Nycomed International Management GmbH, Italy, Category Revenue Share (2009)
10.3.4 Nycomed International Management GmbH, Spain, Category Revenue Share (2009)
10.3.5 Nycomed International Management GmbH, United Kingdom, Category Revenue Share (2009)
10.3.6 Nycomed International Management GmbH, Other Europe, Category Revenue Share (2009)
10.4 Nycomed International Management GmbH, Middle East and Africa, Category Revenue Share (2009)
10.5 Nycomed International Management GmbH, North America, Category Revenue Share (2009)
10.5.1 Nycomed International Management GmbH, Canada, Category Revenue Share (2009)
10.5.2 Nycomed International Management GmbH, United States, Category Revenue Share (2009)
10.6 Nycomed International Management GmbH, South and Central America, Category Revenue Share (2009)
10.6.1 Nycomed International Management GmbH, Brazil, Category Revenue Share (2009)
10.6.2 Nycomed International Management GmbH, Other South and Central America, Category Revenue Share (2009)
11 Key Employees
12 Key Employee Biographies
13 Company Statement
14 Locations And Subsidiaries
14.1 Head Office
14.2 Other Locations & Subsidiaries
15 Financial Deals Landscape
15.1 Nycomed International Management GmbH, Deals Volume Summary, 2005 to YTD 2010
16 Nycomed International Management GmbH, Deals Summary By Region, 2005 to YTD 2010
17 Nycomed International Management GmbH Detailed Deal Summary
17.1 Partnerships
17.1.1 GE Healthcare Forms Joint Venture With Nycomed
17.1.2 Baxter Healthcare Signs An Agreement With Nycomed International Management
18 Recent Developments
18.1 Strategy and Business Planning
18.1.1 Aug 10, 2009: Nycomed Seals Agreement with Forest for Daxas
18.2 Legal and Regulatory
18.2.1 Jan 29, 2008: Nycomed And Wyeth Announce Launch Of An Own Generic Version Of Protonix® – Lawsuit To Defend Patent Continues
18.2.2 Jan 29, 2008: Nycomed And Wyeth Announce Launch Of An Own Generic Version Of Protonix® – Lawsuit To Defend Patent Continues
18.2.3 Sep 07, 2007: Nycomed And Wyeth Continue Lawsuit To Defend Patent For Pantoprazole
18.3 Product News
18.3.1 Apr 06, 2010: Nycomed And Baxter Get FDA Clearance For TachoSil
18.3.2 Apr 05, 2010: Nycomed Receives FDA Approval For TachoSil Biodegradable Sealant Patch For Cardiovascular Surgery
18.3.3 Jan 07, 2008: Baxter To Market Nycomed's Tachosil In The United States
19 Appendix
19.1 Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panels
19.7 Consulting
19.8 Currency Conversion
19.9 Contact Us
19.10 Disclaimer
3M Health Care
Advanced Medical Solutions Group Plc
AstraZeneca PLC
B. Braun Melsungen AG
Baxter International Inc.
Biopol Co., Ltd.
BlueSky Medical Group, Inc.
BSN medical GmbH
Casex Industria de Plasticos e Produtos Medicos Ho
Coloplast A/S
CONMED Corporation
ConvaTec
Covidien plc
Derma Sciences, Inc.
Ethicon, Inc.
GlaxoSmithKline plc
Hartmann Group
Hill-Rom, Inc.
Hollister Incorporated
Huntleigh Healthcare Ltd
IGROBE Rodar SL
Innothera
Invacare Corporation
Johnson & Johnson
Karomed
Kinetic Concepts, Inc.
King Pharmaceuticals, Inc.
Laboratoires Urgo
Merck Serono S.A.
Molnlycke Health Care AB
Novartis AG
Ossur hf.
Shionogi Pharma, Inc.
Smith & Nephew Plc
Systagenix Wound Management
Talley Group Limited
THUASNE SA
Vygon SA
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |